Insider Transactions in Q1 2024 at Bridge Bio Pharma, Inc. (BBIO)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 01
2024
|
Randal W. Scott |
SELL
Open market or private sale
|
Indirect |
2,500
-27.78%
|
$85,000
$34.0 P/Share
|
|
Feb 16
2024
|
Brian C Stephenson Secretary, Treasurer & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
18,919
-23.12%
|
$700,003
$37.21 P/Share
|
|
Feb 16
2024
|
Brian C Stephenson Secretary, Treasurer & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
44,996
+35.48%
|
-
|
|
Feb 16
2024
|
Neil Kumar Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
47,922
-0.97%
|
$1,773,114
$37.21 P/Share
|
|
Feb 16
2024
|
Neil Kumar Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
102,249
+2.04%
|
-
|
|
Feb 16
2024
|
Charles J Homcy |
SELL
Payment of exercise price or tax liability
|
Direct |
1,509
-0.12%
|
$55,833
$37.21 P/Share
|
|
Feb 16
2024
|
Charles J Homcy |
BUY
Exercise of conversion of derivative security
|
Direct |
3,760
+0.3%
|
-
|
|
Feb 15
2024
|
Hannah Valantine |
SELL
Open market or private sale
|
Direct |
2,915
-62.3%
|
$107,855
$37.75 P/Share
|
|
Feb 15
2024
|
Hannah Valantine |
BUY
Exercise of conversion of derivative security
|
Direct |
2,915
+38.39%
|
$23,320
$8.45 P/Share
|
|
Jan 16
2024
|
Hannah Valantine |
SELL
Open market or private sale
|
Direct |
2,915
-62.3%
|
$107,855
$37.97 P/Share
|
|
Jan 16
2024
|
Hannah Valantine |
BUY
Exercise of conversion of derivative security
|
Direct |
2,915
+38.39%
|
$23,320
$8.45 P/Share
|